A Phase I-II Study of the Combination of Bendamustine and Pomalidomide with Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma.

被引：1

作者：

Gasparetto, Cristina ^{[1
]}

Green, Michael ^{[2
]}

Srinivasan, Anandgopal ^{[3
]}

Kang, Yubin ^{[4
]}

Rizzieri, David A. ^{[2
]}

Decastro, Carlos ^{[1
]}

Diehl, Louis F. ^{[1
]}

Beaven, Anne ^{[1
]}

Li, Zighuo ^{[1
]}

Rao, Arati V. ^{[5
,6
]}

Garrett, Anderson ^{[1
]}

Tuchman, Sascha ^{[7
]}

Long, Gwynn D. ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC USA

[2] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA

[3] Univ Cambridge, Sch Clin Med, Cambridge, England

[4] Duke Univ, Med, Durham, NC USA

[5] Duke Univ, Div Cellular Therapy, Med, Durham, NC USA

[6] Duke Univ, Duke Canc Inst, Durham, NC USA

[7] Duke Univ, Durham, NC USA

来源：

关键词：

D O I：

10.1182/blood.V126.23.1857.1857

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3